INVA · Innoviva, Inc.

$21.05 +0.05 (+0.24%)

Market Cap

$1.55B

72.25M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pavel Raifeld	Chief Executive Officer	$600,000	$378,000	$2,649,982	$1,748,882	—	$23,333	$5,400,197
Stephen Basso	Chief Financial Officer and President of IST	$475,000	$223,493	$691,087	$765,348	—	$18,348	$2,171,276
Marianne Zhen	Chief Accounting Officer	$420,000	$245,438	$161,599	$229,989	—	$25,833	$1,082,859

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pavel Raifeld	Chief Executive Officer	$503,333	$414,747	—	$1,775,340	—	$23,000	$2,716,420
Matthew Ronsheim	Former President, IST	$289,678	—	$189,988	$591,532	—	$11,550	$1,082,748
Stephen Basso	Chief Financial Officer and Interim President of IST	$454,500	$187,254	$179,988	$166,329	—	$21,726	$1,009,797
Marianne Zhen	Chief Accounting Officer	$404,000	$229,977	$159,990	$147,852	—	$25,500	$967,319

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Larry Edwards	President	$145,750	—	—	—	—	$1,280,432	$1,426,182
Stephen Basso	Chief Financial Officer and Interim President of IST	$164,063	$163,363	—	$845,625	—	$9,000	$1,182,051
Margaret Koziel	Chief Medical Officer	$187,500	$300,000	—	$356,430	—	$123,750	$967,680
Marianne Zhen	Chief Accounting Officer	$400,000	$220,550	$174,997	$104,162	—	$24,500	$924,209
Pavel Raifeld	Chief Executive Officer	$485,000	$361,648	—	—	—	$22,000	$868,648

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pavel Raifeld	Chief Executive Officer	$440,000	$294,333	—	$1,044,300	—	$20,333	$1,798,966
Marianne Zhen	Chief Accounting Officer	$329,167	$178,542	$124,988	$115,934	—	$22,500	$771,131
Larry Edwards	President	$209,576	$349,800	—	—	—	—	$559,376

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pavel Raifeld	Chief Executive Officer	$391,458	$234,952	—	$580,330	—	$64,938	$1,271,138
Marianne Zhen	Chief Accounting Officer	$296,156	$144,520	$125,000	$27,086	—	$21,500	$614,262

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Pavel Raifeld	Chief Executive Officer	$222,000	$123,968	—	$1,570,000	—	$19,000	$1,943,968
Geoffrey Hulme	Interim Principal Executive Officer	$120,319	—	$224,996	—	—	$370,927	$716,242
Marianne Zhen	Chief Accounting Officer	$284,625	$128,081	$124,996	—	—	$21,167	$558,869

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Geoffrey Hulme	Interim Principal Executive Officer	$300,000	$180,000	$355,768	—	—	$20,667	$856,435
Marianne Zhen	Chief Accounting Officer	$275,000	$123,750	$125,001	—	$7,500	$20,667	$551,918

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne Zhen	Chief Accounting Officer	$239,602	$77,524	$124,946	—	$15,000	$20,333	$477,405
Geoffrey Hulme	Interim Principal Executive Officer	$184,375	$110,323	—	—	—	$7,500	$302,198

Executive changes

Person	Role	Change	Effective	Filed
Mark DiPaolo	member of the Board of Directors	Resigned	2026-05-12	2026-05-18
Derek Small	member of the Board of Directors	Resigned	2026-05-12	2026-05-18
Derek Small	Board of Directors	Appointed	2024-04-29	2024-04-30
Stephen Basso	Chief Financial Officer	Appointed	2023-08-21	2023-08-25
Deborah L. Birx	member of the Board of Directors of Innoviva, Inc. and chair of the Audit Committee	Resigned	2023-07-10	2023-07-11
George Bickerstaff, III	director	Retired	—	2023-05-01
George Bickerstaff, III	Chairman of the Board	Retired	—	2023-05-01
Sapna Srivastava, Ph. D.	Board of Directors	Appointed	2023-01-01	2023-01-04
Deborah L. Birx, M.D.	independent director	Appointed	2021-03-09	2021-03-10
Geoffrey L. Hulme	Interim Principal Executive Officer	Terminated	2020-05-20	2020-06-12
Pavel Raifeld	Chief Executive Officer	Appointed	2020-05-20	2020-06-12
Geoffrey L. Hulme	Interim Principal Executive Officer	Terminated	2020-05-20	2020-05-26
Pavel Raifeld	Chief Executive Officer	Appointed	2020-05-20	2020-05-26

Key facts CIK 1080014 CUSIP 45781M101 13F (30d) 276 filings 273 filers Visit website Investor relations